NIH Renews AMRI’s Neurotherapeutic Drug Discovery Support Contract
Albany Molecular Research Inc. has secured a potential 10-year, $39.5 million contract renewal to support a National Institutes of Health program that aims to develop medicines for nervous system disorders. AMRI said Tuesday it will continue to provide medicinal chemistry, absorption, distribution, metabolism and excretion services to the Blueprint Neurotherapeutics Network managed by NIH’s National Institute of Neurological Disorders and […] More